Mandibular Advancement Devices Tali® in Patients With Syndrome of Obstructive Sleep Apnea and Hypopneas

Syndrome of Obstructive Sleep Apnea and Hypopneas Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02878629
• Other study ID #: OAM Tali®
• Status: Completed
• Start date: July 2016
• Est. completion date: August 2019

Study information

• Verified date: August 2019
• Source: ONIRIS
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The main objective is to evaluate middle term compliance (≥ 2 years) of the Mandibular Advancement Devices Tali® in patients with Syndrome of Obstructive Sleep Apnea and Hypopneas.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 254
• Est. completion date: August 2019
• Est. primary completion date: August 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• Patients > 18 years treated with Mandibular Advancement Device Tali® from at least 2 years and at the latest 5 years.

• Patients who agree to participate to the study.

Related Conditions & MeSH terms

• Sleep Apnea Syndromes
• Sleep Apnea, Obstructive
• Syndrome
• Syndrome of Obstructive Sleep Apnea and Hypopneas

Intervention

Device:
• Mandibular Advancement Devices

Locations

Country	Name	City	State
France	Liberal cabinet	Paris

Sponsors (1)

Lead Sponsor	Collaborator
ONIRIS

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	compliance (no stop of the Mandibular Advancement Device)		2 years or more after the beginning of device